인쇄하기
취소

Submission of bioequivalence test reports to be extended

Published: 2007-04-10 06:57:00
Updated: 2007-04-10 06:57:00
The deadline for the bioequivalence test reports of about 250 drugs may be extended, as a number of pharmaceutical firms have failed to submit their test protocols because of a higher cost and tighter schedule, according to the Korea Food and Drug Administration.

The bio equivalency test reports of about 250 drugs should have been presented to the KFDA by the end of last month, but quite a n...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.